NuVasive
-
Spine
NuVasive to Sponsor and Participate at Society for Minimally Invasive Spine Surgery (SMISS) Annual Forum ’22
SAN DIEGO, Sept. 26, 2022 /PRNewswire/ — NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with…
Read More » -
Spine
NuVasive Announces Departure of Chief Commercial Officer
SAN DIEGO, Aug. 9, 2022 /PRNewswire/ — NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally…
Read More » -
Spine
NuVasive Opens Singapore Experience Center for Asia-Pacific region
New center supports the Company’s globalization efforts through increased surgeon training and education in Asia-Pacific region SAN DIEGO, June 29, 2022 /PRNewswire/ — NuVasive, Inc.…
Read More » -
Spine
NuVasive Simplify Cervical Disc Two-level Data Published in Journal of Neurosurgery: Spine
Peer-reviewed results from the two-level multi-center FDA Investigational Device Exemption study reiterate disc’s superiority to ACDF SAN DIEGO, April 21, 2022 /PRNewswire/…
Read More » -
Spine
Intertek Issues First UL 2900-2-1 Certification to Medical Device Manufacturer NuVasive, Inc.
The first UL 2900 certification issued by Intertek EWA-Canada signifies continued diversification of our core competencies and services March 7,…
Read More » -
Financial
NuVasive Announces Fourth Quarter and Full Year 2021 Financial Results and 2022 Outlook
–Pulse platform demonstrates strong performance in early adoption, including first international commercial contracts– –NuVasive Simplify Cervical Disc exceeds expectations in…
Read More » -
Spine
NuVasive Appoints Andrew C. Morton as Chief Human Resources Officer
SAN DIEGO, Jan. 31, 2022 /PRNewswire/ — NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally…
Read More » -
Biologics
NuVasive Receives FDA Clearance for Expanded Indications of Use for Attrax Putty with Company’s Thoracolumbar Interbody Portfolio
Attrax Putty is the first and only synthetic biologic to receive 510(k) clearance for use with thoracolumbar interbody systems SAN…
Read More » -
Spine
NuVasive to Participate in 40th Annual J.P. Morgan Healthcare Conference
SAN DIEGO, Dec. 28, 2021 /PRNewswire/ — NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with…
Read More » -
Biologics
Biocomposites signs distribution agreement with NuVasive Specialized Orthopedics to supply STIMULAN® in Germany
STIMULAN® is the first and only calcium matrix approved as an antibiotic carrier for use in bone and soft tissue…
Read More » -
Financial
NuVasive (NUVA) Up on Rumors of Takeover by Globus Medical
Zacks Equity Research – Zacks / November 16, 2021 NuVasive, Inc. NUVA shares gained nearly 5% to reach $58.90 yesterday, after a takeover…
Read More » -
Financial
Globus Makes Takeover Approach for NuVasive
November 15, 2021 / Bloomberg / By Michelle F Davis Medical device maker Globus Medical Inc. has made a preliminary approach to smaller…
Read More » -
Spine
NuVasive to Sponsor and Participate in Society for Minimally Invasive Spine Surgery Annual Forum ’21
SAN DIEGO, Oct. 28, 2021 /PRNewswire/ — NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with…
Read More » -
Spine
NuVasive Selects PrecisionOS’ Learning VR Simulation To Expand Company’s Market-Leading Spine Education and Training Programs
SAN DIEGO—October 27, 2021 / OrthoSpineNews / — PrecisionOS has expanded its growing network of medical device collaborators with the…
Read More » -
Spine
NuVasive Launches Latest Porous PEEK Implant for Posterior Spine Surgery
SAN DIEGO, Oct. 14, 2021 /PRNewswire/ — NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally…
Read More »